Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00776919 · ClinicalTrials.gov registry record · Phase 3
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne
A Phase 3 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,315
- Enrollment target
NCT00776919 is a Phase 3 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 1,315 participants.
The verdict
NCT00776919, a Phase 3 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,315 participants
- Enrollment target
Study Summary
This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety and Efficacy of a clindamycin / benzoyl peroxide gel in Subjects with Acne Vulgaris
Interventions
- DRUG clindamycin / benzoyl peroxide gel
- DRUG clindamycin gel
- DRUG BPO gel
- DRUG vehicle gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,315 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00776919
The ClinicalTrials.gov registry entry for NCT00776919 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which clindamycin / benzoyl peroxide gel is the first listed.
NCT00776919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00776919 about?
NCT00776919 is a clinical study titled "Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne". This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety and Efficacy of a clindamycin / benzoyl peroxide gel in Subjects with Acne Vulgaris
What is the current status of trial NCT00776919?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,315 participants. The study started on 2008-10. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00776919?
The interventions under investigation include: clindamycin / benzoyl peroxide gel (DRUG), clindamycin gel (DRUG), BPO gel (DRUG), vehicle gel (DRUG).
Who is sponsoring clinical trial NCT00776919?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.